A Multi-Center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva (erlotinib) Following Complete Tumor Resection and with or without Adjuvant Chemotherapy in Patients with Stage IB-IIIA Non-small Cell......

Project: Research

Status	Finished
Effective start/end date	09/26/07 → 06/10/16

Project Details